ABBV's expanding neuroscience portfolio, led by Botox, Vraylar and new launches like Vyalev, continues to fuel top-line ...

As per SNS Insider Research, the prefilled syringes market is projected to grow at a 12.51% CAGR through 2032, driven by biologics demand, patient safety, and innovative drug delivery solutions.Austin ...